Edition:
United Kingdom

USANA Health Sciences Inc (USNA.N)

USNA.N on New York Stock Exchange

75.90USD
19 Jan 2018
Change (% chg)

$1.50 (+2.02%)
Prev Close
$74.40
Open
$74.60
Day's High
$76.10
Day's Low
$74.60
Volume
20,837
Avg. Vol
27,632
52-wk High
$76.10
52-wk Low
$52.55

Latest Key Developments (Source: Significant Developments)

Usana Health Sciences Provides Estimated Impact Of U.S. Tax Reform
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Usana Health Sciences Inc ::USANA HEALTH SCIENCES PROVIDES ESTIMATED IMPACT OF U.S. TAX REFORM.USANA HEALTH SCIENCES INC - ‍TO TAKE A ONE-TIME NON-CASH CHARGE TO ITS INCOME STATEMENT FOLLOWING U.S. TAX REFORM ENACTED ON DECEMBER 22, 2017​.USANA HEALTH SCIENCES - ‍PRELIMINARY ESTIMATE FOR CHARGE RELATED TO U.S. TAX REFORM EXPECTED TO BE ABOUT $33 MILLION, WHICH CO WILL RECOGNIZE IN Q4 2017 ​.USANA HEALTH SCIENCES INC - ‍CHARGE RELATED TO U.S. TAX REFORM LARGELY DUE TO FOREIGN TAX CREDITS AND OTHER DEFERRED TAX ASSETS​.  Full Article

Usana Health Sciences reports Q3 earnings $0.97/shr
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Usana Health Sciences Inc :Usana Health Sciences reports third quarter financial results.Q3 earnings per share $0.97 excluding items.Q3 sales rose 3 percent to $261.8 million.Sees FY 2017 sales $1.03 billion.Q3 earnings per share $0.97.Usana Health Sciences Inc sees ‍2017 earnings per share of approximately $3.70​.Usana Health - ‍audit committee of board assumed direct responsibility for reviewing internal investigation of co's China operations, Babycare ltd​.Usana Health - does not believe amounts related to investigation are quantitatively material or will materially affect financial statements​.Usana Health - ‍voluntarily contacted SEC and united states doj to advise both agencies that an internal investigation is underway​.  Full Article

Usana Health Sciences says Q2 earnings per share $2.07
Tuesday, 26 Jul 2016 

Usana Health Sciences Inc : Company reiterated its consolidated net sales outlook for 2016 . Sees 2016 earnings per share between $7.90 and $8.20 . Usana health sciences reports record second quarter financial results . Q2 earnings per share $2.07 . Q2 sales $258.5 million versus i/b/e/s view $256.7 million . Q2 earnings per share view $2.05 -- Thomson Reuters I/B/E/S .Fy2016 earnings per share view $8.01, revenue view $1.02 billion -- Thomson Reuters I/B/E/S.  Full Article